Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with α-Glucosidase Inhibitory Activity Is Safe and Effective in Humans with Borderline and Mild Type-2 Diabetes
Author:
Affiliation:
1. Research and Development Department, Nippon Supplement, Incorporated., Kita-Ku, Osaka, 531-0076, Japan
2. Ohshima Clinic, Ibaraki, Osaka, 567-0829, Japan
Publisher
Oxford University Press (OUP)
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Link
http://academic.oup.com/jn/article-pdf/131/8/2105/24008640/4w080102105.pdf
Reference31 articles.
1. α-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects;Toeller;Eur. J. Clin. Investig.,1994
2. Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential;Clissold;Drugs,1988
3. Effect of an α-glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes patients;Saito;J. Int. Med. Res.,1998
4. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycaemic control over 3 years (U.K. Prospective Diabetes Study 44);Rury;Diabetes Care,1999
5. LKPNM: a prodrug type ACE-inhibitory derived from fish protein;Fujita;Immunopharmacology,1999
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The impact of botanical fermented foods on metabolic syndrome and type 2 diabetes: a systematic review of randomised controlled trials;Nutrition Research Reviews;2023-10-26
2. Fermented soybean foods and diabetes;Journal of Diabetes Investigation;2023-10-06
3. Fermented foods and metabolic outcomes in diabetes and prediabetes: A systematic review and meta-analysis of randomized controlled trials;Critical Reviews in Food Science and Nutrition;2023-05-19
4. Douchi Peptides VY and SFLLR Improve Glucose Homeostasis and Gut Dysbacteriosis in High‐Fat Diet‐Induced Insulin Resistant Mice;Molecular Nutrition & Food Research;2023-04-04
5. A clinical trial on anti-diabetic efficacy of submerged culture medium of Ceriporia lacerata mycelium;BMC Complementary Medicine and Therapies;2023-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3